Literature DB >> 28182892

Effects of MIP-1α, MIP-3α, and MIP-3β on the Induction of HIV Gag-specific Immune Response with DNA Vaccines.

Ruijiang Song1, Shuqin Liu2, Kam W Leong3.   

Abstract

Transfection of DNA vaccines with chemokines may recruit dendritic cells (DCs) locally to capture the antigenic genes and their gene products to generate enhanced CD8+ cytotoxic T lymphocytes (CTLs). In this study, we investigated the effects of macrophage inflammatory protein (MIP)-1α, MIP-3α, and MIP-3β on human immunodeficiency virus (HIV) Gag DNA vaccination. The chemokine plasmids markedly enhanced the local infiltration of inflammatory cells and increased the presence of CD11c+ B7.2+-activated DCs. MIP-1α and MIP-3α were potent adjuvants in augmenting CTLs and afforded strong protection to immunized animals against challenge with vaccinia virus expressing Gag (vv-Gag). However, decreased humoral response was observed. MIP-3β plasmid did not dramatically alter immunity. The chemokine inoculation time with respect to DNA vaccine priming was also investigated. The injection of pMIP-3α three days before Gag plasmid (pGag) vaccination markedly increased specific CTLs compared with simultaneous injection and led to higher protection against vv-Gag. Immunity was also shifted toward a T-helper type-1 (Th1) response. In contrast, inoculation with pMIP-3α three days after pGag vaccination shifted immunity toward a Th2 response. Our data suggest that administration of a chemokine with DNA vaccines offers a valuable strategy to modulate the efficacy and polarization of specific immunity and that chemokine-antigen timing is critical in determining overall biological effects.
Copyright © 2007 The American Society of Gene Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2016        PMID: 28182892     DOI: 10.1038/mt.sj.6300129

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  2 in total

1.  Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.

Authors:  Zhujun Ao; Lijun Wang; Emelissa J Mendoza; Keding Cheng; Wenjun Zhu; Eric A Cohen; Keith Fowke; Xiangguo Qiu; Gary Kobinger; Xiaojian Yao
Journal:  PLoS One       Date:  2019-05-17       Impact factor: 3.240

2.  Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID-19.

Authors:  Yasemin Ozsurekci; Kubra Aykac; Ahmet Gorkem Er; Burcin Halacli; Mehmet Arasli; Pembe Derin Oygar; Sibel Gürlevik; Burcu Ceylan Cura Yayla; Jale Karakaya; Alparslan Alp; Arzu Topeli; Ali Bülent Cengiz; Murat Akova; Mehmet Ceyhan
Journal:  J Med Virol       Date:  2020-12-01       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.